General Health News · Supplementary · from General Health News
Case 1: Metabolic Syndrome Screening
Patient Presentation
Demographics: 47-year-old male office manager
Chief Complaint: "I've been gaining weight and my doctor told me my blood pressure is creeping up."
History of Present Illness: Mr. Rodriguez presents for a routine annual physical examination. Over the past three years, he reports a gradual weight gain of approximately 30 pounds, which he attributes to a sedentary desk job, frequent fast-food meals, and reduced physical activity since the COVID-19 pandemic. He notes that his pants size has increased from 34 to 40 inches.
He reports occasional headaches, increased thirst, and nocturia (waking twice nightly to urinate). He denies chest pain, dyspnea, or visual changes. He was told at a health fair six months ago that his blood pressure was "borderline high" but did not follow up. His wife has expressed concern about his snoring and witnessed apneic episodes during sleep.
He drinks two to three cans of regular soda daily and consumes alcohol socially (three to four beers per weekend). He does not smoke and has not engaged in structured exercise for over two years.
Past Medical History:
- No prior diagnoses
- No surgical history
- Childhood history unremarkable
Medications:
- Multivitamin daily
- Ibuprofen as needed for headaches
Social History:
- Office manager, sits 8-10 hours per day
- Married with two children
- Diet high in processed foods, refined carbohydrates, and sugary beverages
- No tobacco use; moderate alcohol use
Family History:
- Father: Type 2 diabetes mellitus, coronary artery disease (MI at age 58)
- Mother: Hypertension, hyperlipidemia
- Sister: Gestational diabetes
Physical Examination
- Vital Signs: BP 142/92 mmHg (repeated 138/90 mmHg), HR 82 bpm, RR 16, Temp 98.4°F, SpO2 97%
- General: Obese male in no acute distress
- HEENT: Acanthosis nigricans noted on posterior neck; crowded oropharynx (Mallampati class IV)
- Cardiovascular: Regular rate and rhythm, no murmurs, no JVD
- Respiratory: Clear to auscultation bilaterally
- Abdomen: Central adiposity; waist circumference 42 inches; soft, non-tender, no hepatomegaly
- Extremities: No edema, pulses 2+ bilaterally
- Skin: Acanthosis nigricans in axillae bilaterally; skin tags on neck
Workup and Results
Laboratory Studies:
| Test | Result | Reference Range |
|---|---|---|
| Fasting Glucose | 118 mg/dL | 70-99 mg/dL |
| HbA1c | 6.1% | < 5.7% |
| Total Cholesterol | 244 mg/dL | < 200 mg/dL |
| LDL Cholesterol | 162 mg/dL | < 100 mg/dL |
| HDL Cholesterol | 34 mg/dL | > 40 mg/dL |
| Triglycerides | 238 mg/dL | < 150 mg/dL |
| ALT | 52 U/L | 7-56 U/L |
| AST | 38 U/L | 10-40 U/L |
| Creatinine | 0.9 mg/dL | 0.7-1.3 mg/dL |
| Uric Acid | 7.8 mg/dL | 3.5-7.2 mg/dL |
| hsCRP | 3.8 mg/L | < 1.0 mg/L (low risk) |
| Fasting Insulin | 28 µIU/mL | 2-20 µIU/mL |
Imaging/Additional Studies:
- Liver ultrasound: Hepatic steatosis (fatty liver), no focal lesions
- ASCVD 10-year risk score: 12.4% (borderline-elevated)
- STOP-BANG score: 5 (high risk for obstructive sleep apnea)
Clinical Image
Diagram illustrating the five diagnostic criteria for metabolic syndrome according to the ATP III/IDF harmonized definition. Source: Educational illustration.
Diagnosis
Metabolic Syndrome (ICD-10: E88.81)
Key Diagnostic Criteria (meets 4 of 5 — requires 3 of 5):
- Waist circumference > 40 inches in males (patient: 42 inches)
- Triglycerides ≥ 150 mg/dL (patient: 238 mg/dL)
- HDL < 40 mg/dL in males (patient: 34 mg/dL)
- Blood pressure ≥ 130/85 mmHg (patient: 142/92 mmHg)
- Fasting glucose ≥ 100 mg/dL (patient: 118 mg/dL)
Treatment Plan
- Lifestyle Modification (first-line): Structured weight loss program targeting 7-10% body weight reduction over 6 months; Mediterranean-style diet with caloric restriction; eliminate sugary beverages
- Exercise Prescription: 150 minutes/week moderate-intensity aerobic activity plus 2 days resistance training; start with 10-minute walking sessions and gradually increase
- Pharmacotherapy: Initiate atorvastatin 20 mg daily given elevated ASCVD risk; consider metformin if lifestyle changes do not normalize glucose within 3 months
- Sleep Evaluation: Refer for polysomnography given high STOP-BANG score
- Follow-up: Recheck metabolic panel, lipids, and blood pressure in 3 months; dietitian referral; diabetes prevention program enrollment
- Monitoring: Home blood pressure log; food and activity diary
Key Learning Points
- Metabolic syndrome is diagnosed when 3 of 5 criteria are present and confers a 2-fold increased risk for cardiovascular disease and 5-fold increased risk for type 2 diabetes
- Acanthosis nigricans and elevated fasting insulin are clinical markers of insulin resistance, the pathophysiological driver of metabolic syndrome
- Lifestyle modification (diet, exercise, weight loss) remains the cornerstone of management and can resolve metabolic syndrome in up to 50% of patients
- Non-alcoholic fatty liver disease (NAFLD) is considered the hepatic manifestation of metabolic syndrome and should be screened for in affected patients
- Obstructive sleep apnea is strongly associated with metabolic syndrome and worsens insulin resistance, creating a bidirectional pathological relationship